Signature tau neuropathology in gray and white matter of corticobasal degeneration
about
Neuropathologic, biochemical, and molecular characterization of the frontotemporal dementias.Characterization of tau fibrillization in vitro.Multiparametric MRI to distinguish early onset Alzheimer's disease and behavioural variant of frontotemporal dementiaA mutation affecting the sodium/proton exchanger, SLC9A6, causes mental retardation with tau deposition.Myelin oligodendrocyte basic protein and prognosis in behavioral-variant frontotemporal dementia.Dementia induces correlated reductions in white matter integrity and cortical thickness: a multivariate neuroimaging study with sparse canonical correlation analysis.Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia.Tau PET imaging: present and future directions.Shape analysis of the corpus callosum in Alzheimer's disease and frontotemporal lobar degeneration subtypesWhite matter disease contributes to apathy and disinhibition in behavioral variant frontotemporal dementia.Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brainsExpression of the small heat-shock protein alphaB-crystallin in tauopathies with glial pathology.Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathyFrontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine.The feasibility of white matter volume reduction analysis using SPM8 plus DARTEL for the diagnosis of patients with clinically diagnosed corticobasal syndrome and Richardson's syndrome.Patterns of gray matter atrophy in atypical parkinsonism syndromes: a VBM meta-analysisGenome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsyWhite matter imaging contributes to the multimodal diagnosis of frontotemporal lobar degeneration.The non-fluent/agrammatic variant of primary progressive aphasia.Too much to count on: impaired very small numbers in corticobasal degenerationLinking white matter integrity loss to associated cortical regions using structural connectivity information in Alzheimer's disease and fronto-temporal dementia: the Loss in Connectivity (LoCo) score.Progression of Microstructural Degeneration in Progressive Supranuclear Palsy and Corticobasal Syndrome: A Longitudinal Diffusion Tensor Imaging Study.Patterns of MRI atrophy in tau positive and ubiquitin positive frontotemporal lobar degenerationCriteria for the diagnosis of corticobasal degenerationDisruption of large-scale neural networks in non-fluent/agrammatic variant primary progressive aphasia associated with frontotemporal degeneration pathology.Imaging in-vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm.White matter imaging helps dissociate tau from TDP-43 in frontotemporal lobar degenerationComparative survey of the topographical distribution of signature molecular lesions in major neurodegenerative diseases.Genetic and neuroanatomic associations in sporadic frontotemporal lobar degeneration.Other dementias.Dystonia in corticobasal degeneration: a review of the literature on 404 pathologically proven cases.MRI signatures of the frontotemporal lobar degeneration continuum.Atypical association of semantic dementia, corticobasal syndrome, and 4R tauopathy.Diffusion tensor magnetic resonance imaging for single subject diagnosis in neurodegenerative diseases.Multimodal imaging evidence of pathology-mediated disease distribution in corticobasal syndrome.Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia.Cellular tau pathology and immunohistochemical study of tau isoforms in sporadic tauopathies.From progressive nonfluent aphasia to corticobasal syndrome: a case report of corticobasal degeneration.PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI).Clinicopathologic analysis of progressive non-fluent aphasia and corticobasal degeneration: Case report and review.
P2860
Q30989766-ACB6FE14-C0A6-433F-844C-E7EDBDC58E47Q33742830-1090EAC4-8FAF-43F0-8B35-FC3DB764231EQ33763640-68BB5077-47CE-43F0-9057-3B59EA4E9E50Q33808422-0145222B-7EC0-4BDE-89D1-CC805F2DA3FBQ34079305-D39FF6EE-5FC0-4B48-958B-C41AA3E2BD30Q34192812-750BD883-0EB8-4C60-8A5C-26EC07D113AAQ34552887-AE6FEB54-CB0E-4471-8033-E97F8651A93BQ34680852-1487DDD6-068D-4008-8760-2933A6D2592CQ34888758-980E6C4F-5E19-4E14-AAD0-51A525010F9AQ34977311-2A557ECA-79EE-48D5-A02B-27618B1870A3Q35009550-C9C3CFAF-F34B-42A4-BC58-10F7190E748DQ35083342-A4F753BC-36F7-40C6-B4C4-E62A9244B434Q35158609-0BB79A14-6F51-46DC-9B46-2274904AD5FCQ35204586-60A09B42-84E0-4BFD-8FE7-AF9311ABD46FQ35693075-77E2A1A6-7351-4E7B-B0A0-9B1632709AC7Q35743561-2EA07FF1-87C4-497D-AFDF-393235CBB2D2Q35750009-804B21FB-116E-4FC5-93EC-BCBD137DEB0AQ35985984-D38CF077-EF7C-4F63-8663-B03918D6F5B4Q35992776-2AA7B3A3-F334-4776-A2C0-454644F3BBA2Q36002837-EAC6DDB0-8973-4C5C-9A2C-5EB3678C54F4Q36038182-71DA79A6-4CD8-41C7-9893-7D77EC990CF6Q36054174-3D01D09F-40E2-4786-BCCC-361DCE04E563Q36172621-084C4BF7-AB85-4AFE-8787-D7992E50B407Q36661843-FD8D2844-21AD-45EA-8530-8F7CEF2ECF87Q36724611-F8BFB30D-AA92-4277-9B0E-B10261299A46Q37063163-B27CC989-C252-44EC-9BE9-2700F9997B0CQ37079742-2E93F3E0-9982-4762-A21D-012D62AAD316Q37412619-56A277B8-B935-409A-BB35-DCCA88BBB04DQ37652962-53EDCFB1-68BA-413E-96B3-D68E28D00C99Q37921665-C42F2272-694F-4B68-91A5-A3AF56D9CE8CQ38006910-F9244A0C-294D-43CA-B976-B192F5F65F2FQ38414131-B56B17A5-9026-4423-8F25-BB72DDCA1289Q38442456-D443EF68-8748-44DD-BB23-E5C3262A3251Q38450602-D54A2907-182B-4A60-9E5A-A2358D9B9616Q41178004-DE560774-F95B-4D84-82FD-263839219471Q42473091-AFA891E4-53E5-4793-8663-4FAB413C2EDDQ42503599-843F14C9-0F43-432D-BBBC-3512BCC57848Q42505843-EAD3B5AC-62BC-4B46-9105-F5422F12CBD3Q46566966-06AB4961-45BA-4344-A2AE-F1A50E550748Q47112181-066536A4-4E12-430F-AF7F-D78D1ABB7013
P2860
Signature tau neuropathology in gray and white matter of corticobasal degeneration
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Signature tau neuropathology in gray and white matter of corticobasal degeneration
@ast
Signature tau neuropathology in gray and white matter of corticobasal degeneration
@en
type
label
Signature tau neuropathology in gray and white matter of corticobasal degeneration
@ast
Signature tau neuropathology in gray and white matter of corticobasal degeneration
@en
prefLabel
Signature tau neuropathology in gray and white matter of corticobasal degeneration
@ast
Signature tau neuropathology in gray and white matter of corticobasal degeneration
@en
P2093
P2860
P1476
Signature tau neuropathology in gray and white matter of corticobasal degeneration
@en
P2093
Catherine Bergeron
Chris Clark
Mark S Forman
Steven S-M Chin
Victoria Zhukareva
Virginia M-Y Lee
P2860
P304
P356
10.1016/S0002-9440(10)61154-6
P407
P577
2002-06-01T00:00:00Z